-
Je něco špatně v tomto záznamu ?
Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition
J. Remšík, L. Binó, Z. Kahounová, G. Kharaishvili, Š. Šimecková, R. Fedr, T. Kucírková, S. Lenárt, XM. Muresan, E. Slabáková, L. Knopfová, J. Bouchal, M. Král, P. Beneš, K. Soucek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV15-33999A
MZ0
CEP - Centrální evidence projektů
NV15-28628A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
Medline Complete (EBSCOhost)
od 1996-01-01 do Před 1 rokem
PubMed
30010814
DOI
10.1093/carcin/bgy095
Knihovny.cz E-zdroje
- MeSH
- antigeny nádorové genetika metabolismus MeSH
- CD antigeny biosyntéza MeSH
- epitelo-mezenchymální tranzice fyziologie MeSH
- epitelové buňky metabolismus MeSH
- kadheriny biosyntéza MeSH
- karcinom patologie MeSH
- lidé MeSH
- metylace DNA genetika MeSH
- molekuly buněčné adheze genetika metabolismus MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- nádory prostaty mortalita patologie MeSH
- nádory prsu mortalita patologie MeSH
- progrese nemoci MeSH
- xenogenní modely - testy protinádorové aktivity MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The cell surface glycoprotein Trop-2 is commonly overexpressed in carcinomas and represents an exceptional antigen for targeted therapy. Here, we provide evidence that surface Trop-2 expression is functionally connected with an epithelial phenotype in breast and prostate cell lines and in patient tumor samples. We further show that Trop-2 expression is suppressed epigenetically or through the action of epithelial-to-mesenchymal transition transcription factors and that deregulation of Trop-2 expression is linked with cancer progression and poor patient prognosis. Moreover, our data suggest that the cancer plasticity-driven intratumoral heterogeneity in Trop-2 expression may significantly contribute to response and resistance to therapies targeting Trop-2-expressing cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028321
- 003
- CZ-PrNML
- 005
- 20241217090038.0
- 007
- ta
- 008
- 190813s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/carcin/bgy095 $2 doi
- 035 __
- $a (PubMed)30010814
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Remšík, Ján $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition / $c J. Remšík, L. Binó, Z. Kahounová, G. Kharaishvili, Š. Šimecková, R. Fedr, T. Kucírková, S. Lenárt, XM. Muresan, E. Slabáková, L. Knopfová, J. Bouchal, M. Král, P. Beneš, K. Soucek,
- 520 9_
- $a The cell surface glycoprotein Trop-2 is commonly overexpressed in carcinomas and represents an exceptional antigen for targeted therapy. Here, we provide evidence that surface Trop-2 expression is functionally connected with an epithelial phenotype in breast and prostate cell lines and in patient tumor samples. We further show that Trop-2 expression is suppressed epigenetically or through the action of epithelial-to-mesenchymal transition transcription factors and that deregulation of Trop-2 expression is linked with cancer progression and poor patient prognosis. Moreover, our data suggest that the cancer plasticity-driven intratumoral heterogeneity in Trop-2 expression may significantly contribute to response and resistance to therapies targeting Trop-2-expressing cells.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a CD antigeny $x biosyntéza $7 D015703
- 650 _2
- $a antigeny nádorové $x genetika $x metabolismus $7 D000951
- 650 _2
- $a nádory prsu $x mortalita $x patologie $7 D001943
- 650 _2
- $a kadheriny $x biosyntéza $7 D015820
- 650 _2
- $a karcinom $x patologie $7 D002277
- 650 _2
- $a molekuly buněčné adheze $x genetika $x metabolismus $7 D015815
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a metylace DNA $x genetika $7 D019175
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a epitelové buňky $x metabolismus $7 D004847
- 650 _2
- $a epitelo-mezenchymální tranzice $x fyziologie $7 D058750
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a nádory prostaty $x mortalita $x patologie $7 D011471
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Binó, Lucia $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. $7 xx0326742
- 700 1_
- $a Kahounová, Zuzana $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Kharaishvili, Gvantsa $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Šimecková, Šárka $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Fedr, Radek $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Kucírková, Tereza $u Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Lenárt, Sára $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Muresan, Ximena Maria $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Slabáková, Eva $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Knopfová, Lucia $u Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Bouchal, Jan $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Král, Milan $u Department of Urology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Beneš, Petr $u Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Soucek, Karel $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 773 0_
- $w MED00001050 $t Carcinogenesis $x 1460-2180 $g Roč. 39, č. 11 (2018), s. 1411-1418
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30010814 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20241217090035 $b ABA008
- 999 __
- $a ok $b bmc $g 1433470 $s 1066781
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 39 $c 11 $d 1411-1418 $e 20181213 $i 1460-2180 $m Carcinogenesis $n Carcinogenesis $x MED00001050
- GRA __
- $a NV15-33999A $p MZ0
- GRA __
- $a NV15-28628A $p MZ0
- LZP __
- $a Pubmed-20190813